<?xml version="1.0" encoding="UTF-8"?>
<ref id="B78-ijms-21-01376">
 <label>78.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Li</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Trang</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Tang</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Xing</surname>
    <given-names>X.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Engineered RNase P ribozymes effectively inhibit the infection of murine cytomegalovirus in animals</article-title>
  <source>Theranostics</source>
  <year>2018</year>
  <volume>8</volume>
  <fpage>5634</fpage>
  <lpage>5644</lpage>
  <pub-id pub-id-type="doi">10.7150/thno.27776</pub-id>
  <?supplied-pmid 30555569?>
  <pub-id pub-id-type="pmid">30555569</pub-id>
 </element-citation>
</ref>
